human leukemic cell lines nalm 6 Search Results


95
ATCC human b cell lines
Human B Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human b cell lines/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
human b cell lines - by Bioz Stars, 2024-12
95/100 stars
  Buy from Supplier

96
ATCC human b cell leukemia cell line nalm6 cells
MPC inhibition dramatically improves human CD19-CAR T cell therapy in a xenograft leukemia model (A) Experimental scheme. (B) Fold expansion after 9 days of culture (n = 3 human donors/group). (C–E) Percentage CD62L-positive CD8 + T cells (C) and median fluorescent intensity (MFI) of CD62L in the CD62L-positive population (D), and representative histogram from one donor (E). (F) Percentage of stem cell-like memory CD8 + T cells, measured by flow cytometry. In (C)–(F), n = 7 human donors/group; pooled data from 2 independent experiments. (G) Western blot quantification of H3K27 acetylation shown as fold change compared with DMSO (n = 5 human donors/group; pooled data from 2 independent experiments). (H) Experimental scheme. (I and J) Histogram of CD62L expression (I) and FACS plot showing CD45-RO and CCR7 expression (J) in CD8 + T cells from a representative donor, 7 days after transduction (EM, effector memory; CM, central memory; SCM, stem cell-like memory). (K) Overall survival. (L) Number of <t>NALM6</t> cells in the blood (n = 4 mice for untreated, n = 5 mice for NTD DMSO and NTD MPCi, n = 7 mice for CAR DMSO, and n = 8 mice for CAR MPCi; pooled data from 2 independent experiments). Data are represented as mean ± SEM. Statistics are based on paired, two-tailed Student’s t test (B–D and F–G), log rank test (K), or two-way ANOVA using Fisher’s LSD test (L), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, or as indicated. See also <xref ref-type=Figure S7 . " width="250" height="auto" />
Human B Cell Leukemia Cell Line Nalm6 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human b cell leukemia cell line nalm6 cells/product/ATCC
Average 96 stars, based on 1 article reviews
Price from $9.99 to $1999.99
human b cell leukemia cell line nalm6 cells - by Bioz Stars, 2024-12
96/100 stars
  Buy from Supplier

86
DSMZ human nalm 6

Human Nalm 6, supplied by DSMZ, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human nalm 6/product/DSMZ
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
human nalm 6 - by Bioz Stars, 2024-12
86/100 stars
  Buy from Supplier

86
Thermo Fisher human cell lines nalm 6

Human Cell Lines Nalm 6, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cell lines nalm 6/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
human cell lines nalm 6 - by Bioz Stars, 2024-12
86/100 stars
  Buy from Supplier

86
CEM Corporation human leukemia nalm 6

Human Leukemia Nalm 6, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human leukemia nalm 6/product/CEM Corporation
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
human leukemia nalm 6 - by Bioz Stars, 2024-12
86/100 stars
  Buy from Supplier

Image Search Results


MPC inhibition dramatically improves human CD19-CAR T cell therapy in a xenograft leukemia model (A) Experimental scheme. (B) Fold expansion after 9 days of culture (n = 3 human donors/group). (C–E) Percentage CD62L-positive CD8 + T cells (C) and median fluorescent intensity (MFI) of CD62L in the CD62L-positive population (D), and representative histogram from one donor (E). (F) Percentage of stem cell-like memory CD8 + T cells, measured by flow cytometry. In (C)–(F), n = 7 human donors/group; pooled data from 2 independent experiments. (G) Western blot quantification of H3K27 acetylation shown as fold change compared with DMSO (n = 5 human donors/group; pooled data from 2 independent experiments). (H) Experimental scheme. (I and J) Histogram of CD62L expression (I) and FACS plot showing CD45-RO and CCR7 expression (J) in CD8 + T cells from a representative donor, 7 days after transduction (EM, effector memory; CM, central memory; SCM, stem cell-like memory). (K) Overall survival. (L) Number of NALM6 cells in the blood (n = 4 mice for untreated, n = 5 mice for NTD DMSO and NTD MPCi, n = 7 mice for CAR DMSO, and n = 8 mice for CAR MPCi; pooled data from 2 independent experiments). Data are represented as mean ± SEM. Statistics are based on paired, two-tailed Student’s t test (B–D and F–G), log rank test (K), or two-way ANOVA using Fisher’s LSD test (L), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, or as indicated. See also <xref ref-type=Figure S7 . " width="100%" height="100%">

Journal: Cell Metabolism

Article Title: The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function

doi: 10.1016/j.cmet.2022.03.013

Figure Lengend Snippet: MPC inhibition dramatically improves human CD19-CAR T cell therapy in a xenograft leukemia model (A) Experimental scheme. (B) Fold expansion after 9 days of culture (n = 3 human donors/group). (C–E) Percentage CD62L-positive CD8 + T cells (C) and median fluorescent intensity (MFI) of CD62L in the CD62L-positive population (D), and representative histogram from one donor (E). (F) Percentage of stem cell-like memory CD8 + T cells, measured by flow cytometry. In (C)–(F), n = 7 human donors/group; pooled data from 2 independent experiments. (G) Western blot quantification of H3K27 acetylation shown as fold change compared with DMSO (n = 5 human donors/group; pooled data from 2 independent experiments). (H) Experimental scheme. (I and J) Histogram of CD62L expression (I) and FACS plot showing CD45-RO and CCR7 expression (J) in CD8 + T cells from a representative donor, 7 days after transduction (EM, effector memory; CM, central memory; SCM, stem cell-like memory). (K) Overall survival. (L) Number of NALM6 cells in the blood (n = 4 mice for untreated, n = 5 mice for NTD DMSO and NTD MPCi, n = 7 mice for CAR DMSO, and n = 8 mice for CAR MPCi; pooled data from 2 independent experiments). Data are represented as mean ± SEM. Statistics are based on paired, two-tailed Student’s t test (B–D and F–G), log rank test (K), or two-way ANOVA using Fisher’s LSD test (L), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, or as indicated. See also Figure S7 .

Article Snippet: B16-F10 melanoma cells, Phoenix-Eco cells and the human B cell leukemia cell line NALM6 cells were originally acquired from the American Type Culture Collection.

Techniques: Inhibition, Flow Cytometry, Western Blot, Expressing, Transduction, Two Tailed Test

Journal: Cell Metabolism

Article Title: The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function

doi: 10.1016/j.cmet.2022.03.013

Figure Lengend Snippet:

Article Snippet: B16-F10 melanoma cells, Phoenix-Eco cells and the human B cell leukemia cell line NALM6 cells were originally acquired from the American Type Culture Collection.

Techniques: Staining, Recombinant, Expressing, Lysis, Selection, Purification, Plasmid Preparation, Bicinchoninic Acid Protein Assay, Magnetic Beads, Western Blot, Sequencing, Software

Journal: iScience

Article Title: TIAR and FMRP shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment

doi: 10.1016/j.isci.2023.106543

Figure Lengend Snippet:

Article Snippet: Human: NALM-6 , DSMZ , Cat#ACC 128.

Techniques: Purification, shRNA, Transduction, Recombinant, Reporter Assay, Lysis, Plasmid Preparation, Software